Literature DB >> 12480968

Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients.

Aikaterini Papagianni1, Michalis Kalovoulos, Dimitrios Kirmizis, Andreas Vainas, Anna-Maria Belechri, Efstathios Alexopoulos, Dimitrios Memmos.   

Abstract

BACKGROUND: Recently emerging evidence suggests that endothelial adhesion molecules may participate in atherogenesis. The aim of the present report was to investigate the probable association of circulating ICAM-1, VCAM-1 and E-selectin with atherosclerotic disease in chronic haemodialysis (HD) patients.
METHODS: One hundred and twelve HD patients and 50 age- and sex-matched healthy normotensive controls participated in the study. Atherosclerotic disease in both groups was assessed by measuring intima-media thickness (IMT) and plaque score of the common carotid arteries using an ultrasound scanner. In addition, in a follow-up study, the survival of 81 patients after a mean period of 26 months was analysed in relation to ICAM-1 and VCAM-1 levels.
RESULTS: IMT and plaque score were significantly higher in HD patients compared with control subjects (P < 0.001 and P < 0.0001, respectively). The above ultrasonographic indices were correlated with age both in controls (P = 0.0001 and P = 0.002, respectively) and HD patients (P = 0.0001 and P = 0.0001, respectively). A significant relationship was observed between IMT and systolic blood pressure (BP) both in controls and in HD patients (P = 0.002 and P = 0.01, respectively). In HD patients, plaque score was also correlated with systolic BP (P = 0.02). In HD patients, IMT and plaque score were correlated significantly with log CRP values (P = 0.01 and P = 0.01, respectively). Multivariate analysis showed that log CRP values were a strong independent contributor to plaque score (P = 0.01). IMT was significantly correlated with ICAM-1 and VCAM-1 concentrations (P = 0.0001 and P = 0.003, respectively). Multivariate analysis showed that ICAM-1 concentrations were a strong independent correlate of IMT (P = 0.001). E-selectin concentrations did not show any relation with IMT or plaque score. During the follow-up period, 13 of the 81 patients died. Survival analyses showed that patients with increased ICAM-1 had a shorter survival than patients with normal ICAM-1 values and that serum ICAM-1 levels were a strong predictor of death.
CONCLUSIONS: In HD patients, carotid atherosclerosis is associated with inflammation and circulating levels of soluble adhesion molecules ICAM-1 and VCAM-1. The correlations between serum ICAM-1 and IMT and ICAM-1 and survival may indicate that this molecule could be a marker of a process that contributes to the high mortality of HD patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12480968     DOI: 10.1093/ndt/18.1.113

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  26 in total

1.  Associations of triiodothyronine levels with carotid atherosclerosis and arterial stiffness in hemodialysis patients.

Authors:  Erhan Tatar; Fatih Kircelli; Gulay Asci; Juan Jesus Carrero; Ozkan Gungor; Meltem Sezis Demirci; Suha Sureyya Ozbek; Naim Ceylan; Mehmet Ozkahya; Huseyin Toz; Ercan Ok
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-11       Impact factor: 8.237

2.  Carotid artery thickness in children and young adults with end stage renal disease.

Authors:  Hakan M Poyrazoğlu; Ruhan Düşünsel; Ali Yikilmaz; Nazmi Narin; Ruksan Anarat; Zübeyde Gündüz; Abdulhakim Coşkun; Ali Baykan; Ahmet Oztürk
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

3.  Short-term fenofibrate treatment reduces elevated plasma Lp-PLA2 mass and sVCAM-1 levels in a subcohort of hypertriglyceridemic GOLDN participants.

Authors:  Alexander K Tsai; Brian T Steffen; Jose M Ordovas; Robert Straka; Xia Zhou; Naomi Q Hanson; Donna Arnett; Michael Y Tsai
Journal:  Transl Res       Date:  2011-02-26       Impact factor: 7.012

4.  High soluble vascular cell adhesion molecule-1 concentrations predict long-term mortality in hemodialysis patients.

Authors:  Jia-Feng Chang; Shih-Ping Hsu; Mei-Fen Pai; Ju-Yeh Yang; Hung-Yuan Chen; Hon-Yen Wu; Yu-Sen Peng
Journal:  Int Urol Nephrol       Date:  2013-04-06       Impact factor: 2.370

5.  [Association of malnutrition-inflammation-cardiovascular disease with cognitive deterioration in peritoneal dialysis patients].

Authors:  L P Duan; Z X Zheng; Y H Zhang; J Dong
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-06-18

6.  Is low magnesium a clue to arteriovenous fistula complications in hemodialysis?

Authors:  Radojica V Stolic; Aleksandar N Jovanovic; Goran Z Trajkovic; Mirjana M Kostic; Andrijana M Odalovic; Sasa R Sovtic; Maja V Sipic; Slavica D Pajovic; Zorica N Sojevic-Timotijevic
Journal:  Int Urol Nephrol       Date:  2016-01-18       Impact factor: 2.370

7.  Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients.

Authors:  Jie Dong; Yan-Jun Li; Zhi-Kai Yang; Rong Xu
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

8.  Effect of different dialysis modalities on microinflammatory status and endothelial damage.

Authors:  Ana Merino; José Portolés; Rafael Selgas; Raquel Ojeda; Paula Buendia; Javier Ocaña; M Auxiliadora Bajo; Gloria del Peso; Julia Carracedo; Rafael Ramírez; Alejandro Martín-Malo; Pedro Aljama
Journal:  Clin J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 8.237

9.  Zinc deficiency decreased cell viability both in endothelial EA.hy926 cells and mouse aortic culture ex vivo and its implication for anti-atherosclerosis.

Authors:  Young-Eun Cho; Jee-Eun Choi; Md Jahangir Alam; Man-Hyo Lee; Ho-Yong Sohn; John H Beattie; In-Sook Kwun
Journal:  Nutr Res Pract       Date:  2008-06-30       Impact factor: 1.926

10.  Pleiotropic vasoprotective effects of statins: the chicken or the egg?

Authors:  Dimitrios Kirmizis; Dimitrios Chatzidimitriou
Journal:  Drug Des Devel Ther       Date:  2009-09-21       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.